Narcolepsy: Independent Evidence on Treatments, Supplements & Safety
Excessive daytime sleepiness & cataplexy — evidence-based treatments are prescription drugs; no supplement has adequate evidence. Independent human-trial evidence, funding traced.
Evidence-graded research on sleep and insomnia — melatonin, magnesium and other sleep supplements assessed by the real strength of the primary evidence.
Excessive daytime sleepiness & cataplexy — evidence-based treatments are prescription drugs; no supplement has adequate evidence. Independent human-trial evidence, funding traced.
Key takeaways Strongest evidence: 300–600 mg/day of standardized root extract for 8 weeks lowers perceived stress and cortisol in adults with self-reported stress, based on a 2025 meta-analysis of 15 randomized trials in 873 people (Bachour et al. 2025, BJPsych Open). Cortisol reduction is more consistently replicated than “less stress” — a separate 2025 review … Read more
Key takeaways Melatonin is the only sleep supplement with strong evidence — but specifically for jet lag and circadian phase shift, not chronic insomnia (Cochrane review). A JAMA analysis found melatonin gummies’ actual content varied widely from label claims, and some products contained undisclosed CBD — a quality problem, not just an efficacy one. Magnesium … Read more
Key takeaways CBT-I (cognitive behavioral therapy for insomnia) is the guideline-recommended first-line treatment for chronic insomnia — not medication or sleep hygiene alone (ACP guideline; AASM behavioral guideline). A meta-analysis of 20 RCTs (1,162 participants) found multimodal CBT-I cut sleep-onset latency by ~19 minutes and wake-after-sleep-onset by ~26 minutes (Annals of Internal Medicine). Sleep hygiene … Read more
Key takeaways Best-supported use: pairing 100–200 mg L-theanine with caffeine (50–100 mg) to reduce jitter and improve sustained attention on cognitive tasks — multiple RCTs and one systematic review support the combination effect (Nutritional Neuroscience, Camfield 2014). For acute situational stress and anxiety, small RCTs (200–400 mg) show reductions in self-rated stress and salivary cortisol … Read more
Key takeaways Strongest evidence: correcting low dietary intake, migraine prevention (300–600 mg daily under medical supervision), and modest blood-pressure reduction — with meta-analyses supporting a systolic drop of ~2 mmHg (Cochrane, Journal of Human Hypertension). For sleep, anxiety, muscle cramps, depression, diabetes, and bone health, evidence is mixed to weak — a systematic review found … Read more
Key takeaways Melatonin is a timing signal, not a sedative — strongest evidence is for jet lag (Cochrane: 8 of 10 trials showed benefit; 0.5–5 mg equally effective, higher doses not better) and delayed sleep-wake phase disorder. For chronic adult insomnia, AASM explicitly recommends against it — the recommendation is graded weak based on small … Read more
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.